Dolasetron mesylate

Revision as of 15:25, 4 June 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drug header

WikiDoc Resources for Dolasetron mesylate

Articles

Most recent articles on Dolasetron mesylate

Most cited articles on Dolasetron mesylate

Review articles on Dolasetron mesylate

Articles on Dolasetron mesylate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dolasetron mesylate

Images of Dolasetron mesylate

Photos of Dolasetron mesylate

Podcasts & MP3s on Dolasetron mesylate

Videos on Dolasetron mesylate

Evidence Based Medicine

Cochrane Collaboration on Dolasetron mesylate

Bandolier on Dolasetron mesylate

TRIP on Dolasetron mesylate

Clinical Trials

Ongoing Trials on Dolasetron mesylate at Clinical Trials.gov

Trial results on Dolasetron mesylate

Clinical Trials on Dolasetron mesylate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dolasetron mesylate

NICE Guidance on Dolasetron mesylate

NHS PRODIGY Guidance

FDA on Dolasetron mesylate

CDC on Dolasetron mesylate

Books

Books on Dolasetron mesylate

News

Dolasetron mesylate in the news

Be alerted to news on Dolasetron mesylate

News trends on Dolasetron mesylate

Commentary

Blogs on Dolasetron mesylate

Definitions

Definitions of Dolasetron mesylate

Patient Resources / Community

Patient resources on Dolasetron mesylate

Discussion groups on Dolasetron mesylate

Patient Handouts on Dolasetron mesylate

Directions to Hospitals Treating Dolasetron mesylate

Risk calculators and risk factors for Dolasetron mesylate

Healthcare Provider Resources

Symptoms of Dolasetron mesylate

Causes & Risk Factors for Dolasetron mesylate

Diagnostic studies for Dolasetron mesylate

Treatment of Dolasetron mesylate

Continuing Medical Education (CME)

CME Programs on Dolasetron mesylate

International

Dolasetron mesylate en Espanol

Dolasetron mesylate en Francais

Business

Dolasetron mesylate in the Marketplace

Patents on Dolasetron mesylate

Experimental / Informatics

List of terms related to Dolasetron mesylate

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Why this medication is prescribed

Dolasetron is used to prevent nausea and vomiting caused by cancer chemotherapy, anesthesia, or surgery. Dolasetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the vomiting reflex in the brain.

How this medication should be used

Dolasetron comes as a tablet to take by mouth. It is usually taken within 1 hour before chemotherapy or within 2 hours before surgery. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take dolasetron exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Other uses for this medicine

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Special precautions

Before taking dolasetron:

  • tell your doctor and pharmacist if you are allergic to dolasetron, alosetron (Lotronex), granisetron (Kytril), ondansetron (Zofran), or any other medications.
  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: cimetidine (Tagamet); cisapride (Propulsid); diuretics ('water pills'); dofetilide (Tikosyn); erythromycin (E.E.S., E-Mycin, Erythrocin); medications for irregular heartbeat such as amiodarone (Cordarone), disopyramide (Norpace), pimozide (Orap), procainamide (Procanbid, Pronestyl), quinidine (Quinidex), and sotalol (Betapace, Betapace AF); moxifloxacin (Avelox); rifampin (Rifadin, Rimactane); sparfloxacin (Zagam); and thioridazine (Mellaril). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • tell your doctor if you have or have ever had low blood levels of magnesium or potassium, or heart disease.
  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking dolasetron, call your doctor.

Special dietary instructions

Unless your doctor tells you otherwise, continue your normal diet.

What to do if you forget a dose

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Side effects

Minor side effects

Dolasetron may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • headache
  • diarrhea
  • excessive tiredness
  • dizziness
  • pain
  • heartburn
  • chills
  • rash
  • fever
  • itching

Severe side effects

Some side effects can be serious. The following symptom is uncommon, but if you experience it, call your doctor immediately:

  • rapid, pounding , or irregular heartbeat

Dolasetron may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].

Storage conditions needed for this medication

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Symptoms of overdose may include:

  • dizziness
  • fainting

Other information

Keep all appointments with you doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

Brand names

  • Anzemet®

Template:SIB

Template:WH

Template:WS